Innovation Pharmaceuticals (QB) Stock Price

0.007 (2.88%)
Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Innovation Pharmaceuticals Inc (QB) IPIX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.007 2.88% 0.25 0.23 0.26 0.24 0.243 16:22:15
Bid Price Ask Price Spread Spread % News
0.242 0.26 0.018 6.92% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
249 1,689,481 $ 0.244836 $ 413,646 3,663,788 0.05 - 0.65
Last Trade Time Type Quantity Stock Price Currency
16:00:25 formt 2,500 $ 0.24 USD

Innovation Pharmaceuticals (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 82.08M 328.32M 128.46M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
766.19k $ - 0.00% - -

more financials information »

Innovation Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IPIX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.22380.2970.2120.25117972,171,2240.026211.71%
1 Month0.3370.390.1910.27583993,123,133-0.087-25.82%
3 Months0.140.650.1330.31926253,893,8540.1178.57%
6 Months0.07750.650.066950.22886053,493,9540.1725222.58%
1 Year0.14750.650.050.21047392,005,9990.102569.49%
3 Years0.78251.170.050.2381748922,275-0.5325-68.05%
5 Years1.492.480.050.3866163646,766-1.24-83.22%

Innovation Pharmaceuticals (QB) Description

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.